Signaling by HGF and KGF in corneal epithelial cells: Ras/MAP kinase and Jak-STAT pathways

Investigative Ophthalmology and Visual Science

Volumn 39, Issue 8, 1998, Pages 1329-1338

  Liang, Qianwa ^a   Mohan, Rajiv R ^a   Chen, Lisha ^a   Wilson, Steven E ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ADAPTOR PROTEIN; CALPHOSTIN C; DNA; EPIDERMAL GROWTH FACTOR; GENISTEIN; KERATINOCYTE GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOTRANSFERASE; RAS PROTEIN; RECEPTOR; SCATTER FACTOR; STAT1 PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; CONTROLLED STUDY; CORNEA EPITHELIUM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

BLOTTING, WESTERN; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELLS, CULTURED; DNA-BINDING PROTEINS; ENZYME INHIBITORS; EPITHELIUM, CORNEAL; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR 7; FIBROBLAST GROWTH FACTORS; FLAVONOIDS; GENISTEIN; GROWTH SUBSTANCES; HEPATOCYTE GROWTH FACTOR; HUMANS; JANUS KINASE 1; NAPHTHALENES; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS P21(RAS); RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 0031749349     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (97)

1. Wilson SE, Walker JW, Chwang EL, He YG. Hepatocyte growth factor (HGF), keratinocyte growth factor (KGF), their receptors, FGF receptor-2, and the cells of the cornea. Invest Ophthalmol Vis Sci. 1993;34:2544-2561.
2. Wilson SE, Weng J, Chwang EL, Gollahon L, Leitch AM, Shay JW. Hepatocyte growth factor (HGF), keratinocyte growth factor (KGF), and their receptors in human breast cells and tissues: alternative receptors. Cell Mol Biol Res. 1994;40:337-350.
3. Wilson SE, He YG, Weng J, Zieske JD, Jester JV, Schultz GS. Effect of epidermal growth factor, hepatocyte growth factor, and keratinocyte growth factor on proliferation, motility, and differentiation of human corneal epithelial cells. Exp Eye Res. 1994;59:665-678.
4. Rubin JS, Osada H, Finch PW, Taylor WJ, Rudikoff S, Aaronson SA. Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sd USA. 1989; 86:802-806.
5. Rubin JS, Bottaro DP, Aaronson SA. Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product. Biochim Biopbys Acta. 1993;1155:357-371.
6. Rubin JS, Bottaro DP, Chedid M, et al. Keratinocyte growth factor. Cell Biol Int. 1995;19:399-411.
7. Finch PW, Rubin JS, Miki T, Ron D, Aaronson SA. Human KGF is FGF-relatect with properties of paracrine effector of epithelial cell growth. Science. 1989;245:752-755.
8. Montesano R, Matsumoto K, Nakamura T, Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell. 1991;67:901-908.
9. Matsumoto K, Nakamura T. Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological functions. Crit Rev Oncog. 1992;3:27-54.
10. Gherardi E, Sharp M, Lane K, Sirulnik A, Stoker M. Hepatocyte growth factor/scatter factor (HGF/SF), the c-met receptor and the behavior of epithelial cells. Symp Soc Exp Biol. 1993;47:163-181.
11. Rosen EM, Nigam SK, Doldberg I. Scatter factor and c-met receptor: a paradigm for mesenchymal/epithelial interaction. J Cell Biol. 1994;127:1783-1787.
12. Rosen EM, Goldberg ID. Regulation of scatter factor (hepatocyte growth factor) production by tumor-stroma interaction. In: Goldberg ID, Rosen EM, eds. Epithelial-Mesenchymal Interactions in Cancer. Basel, Switzerland: Birkhauser; 1995:17-31.
13. Jeffers M, Rong S, Vande Woude GF. Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signaling in human cells concomitant with induction of the urokinase proteolysis network. Mol Cell Biol. 1996;16:1115-1125.
14. Li Q, Weng J, Mohan RR, et al. Hepatocyte growth factor and hepatocyte growth factor receptor in the lacrimal gland, tears, and cornea. Invest Ophthalmol Vis Sci. 1996;37:727-739.
15. Li DQ, Tseng SC. Three patterns of cytokine expression potentially involved in epithelial-fibroblast interactions of human ocular surface. J Cell Physiol. 1995;163:61-79.
16. Solozono C, Inatomi T, Nakamura M, Kinoshita S. Keratinocyte growth factor accelerates corneal epithelial wound healing in vivo. Invest Ophthalmol Vis Sci. 1995;36:1524-1530.
17. Wilson SE. Molecular cell biology for the refractive corneal surgeon: programmed cell death and wound healing. J Refract Surg. 1997;13:171-175.
18. Weidner KM, Behrens J, Vandekerckhove J, Birchmeier W. Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol. 1990;111:2097-2108.
19. Grant DS, Kleinman HK, Goldberg ID, et al. Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA. 1993;90: 1937-1941.
20. Bussolino F, Di RM, Ziehe M, et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol. 1992;119:629-641.
21. Rong S, Bodescot M, Blair D, et al. Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol Cell Biol. 1992;12:5152-5158.
22. Matsumoto K, Nakamura T. Roles of HGF as a pleiotropic factor in organ regeneration. In: Gildberg ID, Rosen ER, eds. Hepatocyte Growth Factor-Scatter Factor (HGF/SF) and c-met Receptor Basel, Switzerland: Birkhauser; 1993:225-250.
23. Stoker M, Gherardi E. Regulation of cell movement: the motogenic cytokines. Biochim Biopbys Acta. 1991;1072:81-102.
24. Bottaro DP, Rubin JS, Faletto DL, et al. Identification of the hepaocyte growth factor receptor as the c-met proto-oncogene product. Science. 1991;251:802-807.
25. Naldini L, Vigna E, Narshimhan RP, et al. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-met. Oncogens. 1991;6:501-504.
26. Tsarfaty I, Resau JH. Rulong S, Keydar I, Faletto DL, Vande Woode GF. The met proto-oncogene receptor and lumen formation. Science. 1992;257:1258-1261.
27. Nakamura Y, Morishita R, Higaki J, et al. Expression of local hepatocyte growth factor system in vascular tissues. Biochem Biopbys Res Commun. 1995;215:483-488.
28. Graziani A, Gramaglia D, Cantley LC, Comoglio PM. The tyrosinephosphorylated hepatocyte growth factor receptor association with phosphatidylinositol 3-kinase. J Biol Chem. 1991;266:22087-22090.
29. Villa-Moruzzi E, Lapi S, Prat M, Gaudino G, Comoglio PM. A protein tyrosine phosphatase activity associated with the hepatocyte growth factor/scatter factor receptor. J Biol Chem. 1993;268: 18176-18180.
30. Graziani A, Gramaglia D, dalla Zonca P, Comoglio PM. Hepatocyte growth factor/scatter factor stimulates the ras-guanine nucleotide exchanger. J Biol Chem. 1993;268:9165-9168.
31. Ponzetto C, Bardelli A, Zhen Z, et al. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell. 1994;77:261-271.
32. Pelicci G, Giordano S, Zhen Z, et al. The motogenic and mitogenic responses to HGF are amplified by the She adapter protein. Oncogene. 1995;10:1631-1638.
33. Halaban R, Rubin JS, White W. Met and HGF-SF in normal melanocytes and melanoma cells. EXS. 1993;65:329-339.
34. Chatani Y, Itoh A, Tanaka E, Hattori A, Nakamura T, Kohno M. Hepatocyte growth factor rapidly induces the tyrosine phosphorylation of 41-kDa and 43-kDa proteins in mouse keratinocytes. Biochem Biophys Res Commun. 1992;185:860-866.
35. Gines P, Li X, Brown SE, et al. Inhibitory actions of cyclic adenosine monophosphate and pertussis toxin define two distinct epidermal growth factor-regulated pathways leading to activation of mitogen-activated protein kinase in rat hepatocytes. Hepatology. 1996;23:1167-1173.
36. Adachi T, Nakashima S, Saji S, Nakamura T, Nozowa Y. Mitogen-activated protein kinase activation in hepatocyte growth factor-stimulated rat hepatocytes: involvement of protein tyrosine kinase and protein kinase C. Hepatology. 1996;23:1244-1253.
37. Schaper F, Siewert E, Gomez-Lechon MJ, et al. Hepatocyte growth factor/scatter factor (HGF/SF) signals via the STAT3/APRF transcription factor in human hepatoma cells and hepatocytes. FEBS Lett. 1997;405:99-103.
38. Miki T, Bottaro DP, Fleming TP, et al. Determination of ligand-binding specificity by alternative splicing: two distinct growth factor-receptors encoded by a single gene. Proc Natl Acad Sci USA. 1992;89:246-250
39. Yayon A, Zimmer Y, Shen GH, Avivi A, Yarden Y, Givol D. A confined variable region confers ligand specificity on fibroblast growth factor receptors: implications for origin of the immunoglobulin fold. EMBO J. 1992;11:1885-1890.
40. Bottaro DP, Fortney E, Rubin JS, Aaronson SA. A keratinocyte growth factor receptor-derived peptide antagonist identifies part of the ligand binding site. J Biol Chem. 1993;268:9180-9183.
41. Mason IJ, Fuller-Pace F, Smith R, Dickson C. FGF-7 (keratinocyte growth factor) expression during mouse development suggests roles in myogenesis, forebrain regionalisation and epithelial-mesenchymal interaction. Mech Den. 1994;45:15-30.
42. Housley RM, Morris CF, Boyle W, et al. Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract. J Clin Invest. 1994;94:1764-1777.
43. Sachs M, Weidner KM, Brinkmann V, et al. Motogenic and morphogenic activity of epithelial receptor tyrosine kinases. J Cell Biol. 1996;133:1095-1107.
44. Finch PW, Cunha GR, Rubin JS, Wong J, Ron D. Pattern of keratinocyte growth factor and keratinocyte growth factor receptor expression during mouse fetal development suggests a role in mediating morphogenetic mesenchymal-epithelial interactions. Dev Dyn. 1995;203:223-240.
45. Matsubara Y, Ichinose M, Tatematsu M, et al. Stage-specific elevated expression of the genes for hepatocyte growth factor, keratinocyte growth factor, and their receptors during the morphogenesis and differentiation of rat stomach mucosa. Biochem Biopbys Res Commun. 1996;222:669-677.
46. Yi ES, Bedoya AA, Lee H, et al. Interactions of keratinocyte growth factor, estrogen, and progesterone in vivo. Am J Pathol. 1994;145: 1015-1022.
47. Yi ES, Yin S, Harclerode DL, et al. Keratinocyte growth factor induces pancreatic ductal epithelial proliferation. Am J Pathol. 1994;145:80-85.
48. Werner S, Peters KG, Longaker MT, Fuller-Pace F, Banda MJ, Williams LT. Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc Natl Acad Sci U S A. 1992;89:6896-6900.
49. Marchese C, Chedid M, Dirsch OR, et al. Modulation of keratinocyte growth factor and its receptor in reepithelializing human skin. J Exp Med. 1995;182:1369-1376.
50. Werner S, Smola H, Liao X, et al. The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science. 1994;266:819-822.
51. Staiano-Coico L, Kruger JG, Rubin JS, et al. Human keratinocyte growth factor effects in a porcine model of epidermal wound healing. J Exp Med. 1993;178:865-876.
52. Mishima H, Nishida T, Nakamura M, Otori T. Modulation of the stimulatory actions of EGF on the corneal epithelial cells by TGF-beta. Invest Ophthalmol Vis Sci. 1990;31(4):S53. Abstract nr 258.
53. Filipec M, Mai Phan T, Colvin RB, Lui G-M, Foster CS. Effect of EGF, basic FGF, TGF-alpha, and TGF-beta on corneal epithelial wound healing in vitro. Invest Ophthalmol Vis Sci. 1990;31(4): S55. Abstract nr 268
54. Petroutsoso G, Courty J, Guimaraes R, Pouliquen Y. Comparison of the effects of EGF, FGF, and EDGF on corneal epithelium wound healing. Curr Eye Res. 1984;3:593-598.
55. Nakada S, del Cerro M, Aquavella JV, Erdey RA. Effect of PDGF, IGF, and EGF on corneal epithelial wound healing and reinnervation. Invest Ophthalmol Vis Sci. 1990;31(4):S54. Abstract nr 260.
56. Brazzell RK, Stern ME, Aquavella JV, Beuerman RW, Baird L. Human recombinant epidermal growth factor in experimental corneal wound healing. Invest Ophthalmol Vis Sci. 1991;31:336-340.
57. Egan SE, Weinberg RA. The pathway to signal achievement. Nature. 1993;365:781-783.
58. Nakamura K, Zhou CJ, Parante J, Chew CS. Parietal cell MAP kinases: multiple activation pathways. Am J Physiol. 1996;271: G640-G649.
59. Ullrich A, Schlessinger J. Signal transduction by receptor with tyrosine kinase activity. Cell. 1990;61:203-212.
60. Le Panse R, Mitev V, Houdebine LM, Coulomb B. Protein kinase C-independent activation of mitogen-activated protein kinase by epidermal growth factor in skin fibroblasts. Eur J Pharmacol. 1996;307:339-345.
61. Darnell JE, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in responses to IFNs and other extracellular signaling proteins. Science. 1994;264:1415-1421.
62. Zhong Z, Wen Z, Darnell JE. STAT3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science. 1994;264:95-98.
63. Leaman DW, Pisharody S, Flickinger TW, et al. Roles of JAKs in activation of STATs and stimulation of c-fos gene expression by epidermal growth factor. Mol Cell Biol. 1996;16:369-375.
64. Araki-Sasabe K, Ohashi Y, Sasabe T, et al. An SV40-immortalized human corneal epithelial cell line and its characterization. Invest Ophthalmol Vis Sci. 1995;36:614-621.
65. Schindler C, Fu XY, Improta T, Aebersold R, Darnell JE Jr. Proteins of transcription factor ISGF-3: one gene encodes the 91 and 84-kDa ISGF-3 proteins that are activated by interferon alpha. Proc Natl Acad Sci USA. 1992;89:7836-7839.
66. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
67. Liang Q, Richardson T. Expression and characterization of human lactoferrin in yeast Saccharomyces cerevisiae. J Agriculture Food Chem. 1993;41:1800-1807.
68. Sadowski HB, Oilman MZ. Cell-free activation of a DNA-binding protein by epidermal growth factor. Nature. 1993;362:79-83.
69. Matuoka K, Shibasaki F, Shibata M, Takenawa T. Ash/Grb2, a SH2/SH3-containing protein, couples to signaling for mitogenesis and cytoskeletal reorganization by EGF and PDGF. EMBO J. 1993; 12:3467-3473.
70. Meryer S, LaBudda K, McGlade J, Hayman MJ. Analysis of the role of the She and Grb2 proteins in signal transduction by the v-ErbB protein. Mol Cell Biol. 1994;14:3253-3262.
71. Myers MG, Cheatham B, Fisher TL, et al. Common and distinct elements in insulin and PDGF signaling. Ann N Y Acad Sci. 1995; 766:369-387.
72. Byers S, Park M, Sommers C, Seslar S. Breast carcinoma: a collective disorder. Breast Cancer Res Treat. 1994;31:203-215.
73. Ellis MJ, Singer C, Hornby A, Rasmussen A, Cullen KJ. Insulin-like growth factor mediated stromal-epithelial interactions in human breast cancer. Breast Cancer Res Treat. 1994;31:249-261.
74. Kamalati T, Brooks RF, Holder N, Buluwela L. In vitro regulation of HGF-SF expression by epithelial-mesenchymal interactions. EXS. 1993;65:201-224.
75. Buday L, Downward J. Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor. Cell. 1993;73:611-620.
76. Ward CW, Gough KH, Rashke M, Wan SS, Tribbick G, Wang J. Systematic mapping of potential binding sites for She and Grb2 SH2 domains on insulin receptor substrate-1 and the receptors for insulin, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor. J Biol Chem. 1996;271:5603-5609.
77. Zhang XF, Settleman J, Kyriakis JM, et al. Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1. Nature. 1993;364:308-313.
78. Vojtek AB, Hollenberg SM, Cooper JA. Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell. 1993;74:205-214.
79. Hartmann G, Weidner KM, Schwanz H, Birchmeier W. The motility signal of scatter factor/hepatocyte growth factor mediated through the receptor tyrosine kinase Met requires intracellular action of Ran. J Biol Chem. 1994;269:21936-21939.
80. Ridley AJ, Comoglio PM, Hall A, Regulation of scatter factor/hepatocyte growth factor responses by Ras, Rac, and Rho in MDCK cells. Mol Cell Biol. 1995;15:1110-1122.
81. Besser D, Bardelli A, Didichenko S, et al. Regulation of the urokinase-type plasminogen activation gene by the oncogene Tpr-Met involves GRB2. Ocogene. 1997;14:705-711.
82. Byrd DA, Sweet DJ, Pante N, et al. Tpr, a large coiled coil protein whose amino terminus is involved in activation of oncogenic kinase, is localized to the cytoplasmic surface of the nuclear pore complex. J Cell Biol. 1994;127:1515-1526.
83. Yamazaki T, Tobe K, Hoh E, et al. Mechanical loading activates mitogen-activated protein kinase and S6 peptide kinase in cultured rat cardiac myocytes. J Biol Chem. 1993;268:12069-12075.
84. Cacace AM, Ueffing M, Philipp A, Han EKH, Kolch W, Weinstein IB. PKC epsilon functions as an oncogene by enhancing activation of the Raf kinase. Oncogene. 1996;13:2517-2526.
85. Morrison DK, Kaplan DR, Rapp U, Robberts TM. Signal transduction from membrane to cytoplasm: growth factors and membrane-bound oncogene products increase Raf-1 phosphorylation and associated protein kinase activity. Proc Natl Acacl Sci USA. 1988; 85:8855-8859.
86. Kolch W, Heidecker G, Kochs G, et al. Protein kinase Ca activates raf-1 by direct phosphorylation. Nature. 1993;364:249-252.
87. Le Panse R, Mitev V, Lebreton C, Coulomb B. Modulation of epidermal growth factor and keratinocyte growth factor effects on human keratinocyte growth by protein kinase C. Biochem Biopbys Res Commun. 1994;204:1081-1087.
88. Tarnawski A, Halter F. Cellular mechanisms, interactions, and dynamics of gastric ulcer healing. J Clin Gastroenterol. 1995; 21(suppl)1:S93-97.
89. Byrne RL, Leung H, Neal DE. Peptide growth factors in the prostate as mediators of stromal epithelial interaction. Br J Urol. 1996;77:627-633.
90. Maruo T, Matsuo H, Otani T, Mochizuki M. Role of epidermal growth factor (EGF) and its receptor in the development of the human placenta. Reprod Fertil Dev. 1995;7:1465-1470.
91. Moulin V. Growth factors in skin wound healing. Enr J Cell Biol. 1995;68:1-7.
92. Price JT, Wilson HM, Haites NE. Epidermal growth factor (EGF) increases the in vitro invasion, motility and adhesion interactions of the primary renal carcinoma cell line, A704. Eur J Cancer. 1996;32A:1977-1982.
93. McCawley LJ, O'Brien P, Hudson LG. Overexpression of the epidermal growth factor receptor contributes to enhanced ligand-mediated motility in keratinocyte cell lines. Endocrinology. 1997; 138:121-127.
94. Chao MV. Growth factor signaling: where is the specificity? Cell. 1992;68:995-997.
95. Johnson M, Kochhar K, Nakamura T, Lyer A. Hepatocyte growth factor-induced signal transduction in two normal mouse epithelial cell lines. Biochem Mol Biol Int. 1995;36:465-474.
96. Iwama A, Yamaguchi N, Suda T. STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family. EMBO J. 1996;15:5866-5875.
97. Nagamine K, Shibamoto S, Takeuchi K, et al. Dissociation of c-fos induction and mitogen-activated-protein kinase activation from the hepatocyte-growth-factor-induced motility response in human gastric carcinoma cells. Eur J Biocbem. 1996;236:476-481.